Systane Balance, 10 ml
Lubricating eye drops for dry and unstable tear film
Category: Eye Care
Purpose: Relieves dry eye symptoms and restores tear film stability
🌿 What It Is
Systane Balance is a therapeutic eye drop designed for individuals suffering from dry eyes caused by meibomian gland dysfunction or lipid layer deficiency. Its unique microemulsion formula contains dimyristoyl phosphatidyl glycerol (DMPG) and mineral oil, which help restore the lipid layer of the tear film, reduce evaporation, and provide long-lasting relief from irritation, redness, and discomfort.
✅ Key Benefits
Provides fast and long-lasting relief from dry eye symptoms
Restores tear film lipid layer to reduce evaporation
Improves ocular comfort and moisture retention
Suitable for contact lens wearers
Helps prevent irritation caused by environmental factors
🧴 Use & Dosage
Shake the bottle gently before use.
Tilt your head back and place 1–2 drops in the affected eye(s).
Blink several times to distribute the solution evenly.
Use up to 4 times daily or as recommended by your eye care professional.
⚠️ Safety & Precautions
For ophthalmic use only
Avoid touching the tip of the bottle to the eye or any surface
Discontinue use if irritation or discomfort persists
Use under medical supervision if you have eye infections or chronic conditions
Store in a cool, dry place and keep out of reach of children
📦 Product Details
Form: Eye drops
Active Ingredients: Dimyristoyl phosphatidyl glycerol (DMPG), mineral oil, polyethylene glycol, propylene glycol
Target Group: Adults and children experiencing dry eye or tear film instability
Pack Size: 10 ml
🛒 Buy Systane Balance, 10 ml
Relieve dryness and restore tear film stability with Systane Balance — available now at Mypharmacy24!
🔑 SEO Keywords:
Systane Balance eye drops, dry eye relief, tear film stabilizer, Systane lubricant drops, DMPG eye drops, eye hydration drops, Systane Balance 10 ml, meibomian gland support, anti-evaporation eye drops, dry eye treatment.
.






Reviews
Clear filtersThere are no reviews yet.